Anti Asthma Drugs Market Strategies and Share 2031
The Anti Asthma Drugs Market is expected to register a CAGR of 5.5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Anti-Asthma Drugs Market Report is segmented by type of asthma into Allergic and Non-allergic. The asthma trigger type segment includes Child-Onset Asthma, Adult-Onset Asthma, Exercise-Induced Asthma, Cough-Induced Asthma, Occupational Asthma, Nocturnal Asthma, and Steroid-Resistant Asthma. The drug class segment includes Bronchodilators, Leukotriene Antagonists, Mast Cell Stabilizers, Corticosteroids, and Monoclonal Antibody. The route of administration segment includes Oral, Inhaled, Intravenous, and Subcutaneous. The market evaluation is presented in US$ for the above segmental analysis. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Anti Asthma Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Anti Asthma Drugs Market Segmentation
Type of asthma- Allergic
- Non- allergic
- Child-Onset Asthma
- Adult-Onset Asthma
- Exercise-Induced Asthma
- Cough-Induced Asthma
- Occupational Asthma
- Nocturnal Asthma
- Steroid-Resistant Asthma
- Bronchodilators
- Leukotriene Antagonists
- Mast Cell Stabilizers
- Corticosteroids
- Monoclonal Antibody
- Oral
- Inhaled
- Intravenous
- Subcutaneous
- Oral
- Inhaled
- Intravenous
- Subcutaneous
Strategic Insights
Anti Asthma Drugs Market Growth Drivers- Emerging Biologics and Targeted Therapies: The development of innovative biologics and targeted therapies for severe asthma offers more effective treatment options, driving market growth.
- Increased Prevalence of Asthma: The growing number of asthma cases, particularly in developing countries, is a primary driver for the market's expansion.
- Improved Awareness and Healthcare Infrastructure: Rising awareness about asthma and its management, coupled with enhanced healthcare infrastructure, is leading to earlier diagnoses and more effective treatments.
- New Biologics and Targeted Therapies: The rise of biologics and targeted therapies, such as monoclonal antibodies and small molecule inhibitors, shows great potential for treating severe asthma. These therapies offer more precise and effective treatment options.
- Digital Health Technologies: Wearable devices and telemedicine are transforming asthma management. These technologies enable better symptom monitoring and improve adherence to treatment plans, offering patients continuous interaction with healthcare providers without frequent medication adjustments.
- Preventive Approaches: Increased focus on preventive strategies, such as avoiding allergens and implementing environmental controls, is expected to improve disease management. These measures could lead to reduced dependence on medications, offering patients long-term relief.
- New Delivery Methods: Innovations in smart inhalers and digital health devices offer more efficient ways to deliver medications and enhance patient engagement. These technologies can significantly improve treatment adherence and allow for better monitoring of symptoms.
- Patient-Centric Care: Developing patient-centric care models in collaboration with pharmaceutical companies and healthcare providers can lead to more personalized asthma management. These models will focus on improving the quality of life for asthma patients through tailored treatment plans and better care coordination.
- Emerging Markets: The Asia-Pacific and Latin America regions show substantial growth potential due to rising asthma prevalence and increased healthcare spending. As these regions continue to develop, there will be greater demand for effective asthma treatments.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Anti Asthma Drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Anti Asthma Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Anti Asthma Drugs Market is expected to grow at a CAGR of 5.5% between 2023-2031
The market for anti-asthma drugs is driven by a number of key factors. The prevalence of asthma, especially in developing countries, is increasing. Rising awareness of the disease and improvement in healthcare infrastructure have resulted in earlier diagnosis and treatment. Furthermore, new drug delivery systems such as inhalers and nebulizers have improved patient compliance and effectiveness of the treatment. An increase in the geriatric population, who are more prone to respiratory diseases, is another driver of demand for this market.
Future direction of anti-asthma drugs will be guided by several emerging trends. Tailored medicine with help of genomics and proteomics will usher treatment into patient-centered approaches. Severe asthma is bound to receive treatment using novel biologics and targeted therapy. The adoption of wearable devices and telemedicine shall support digital health technology in guiding self-management in symptom tracking and treatment compliance. It will further increase attention to preventive measures such as allergen avoidance and environmental control, thus improving disease management and reducing reliance on medications.
The leading players of the market are: GlaxoSmithKline Plc., Boehringer Ingelheim GmbH, Merck and Co., Inc., AstraZeneca Plc., F. Hoffmann- La Roche AG, Novartis International AG, Pfizer Inc., Sunovion Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti Asthma Drugs Market - By Type of Asthma
1.3.2 Anti Asthma Drugs Market - By Asthma trigger type
1.3.3 Anti Asthma Drugs Market - By Drug Class
1.3.4 Anti Asthma Drugs Market - By Route of Administration
1.3.5 Anti Asthma Drugs Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTI ASTHMA DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTI ASTHMA DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTI ASTHMA DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI ASTHMA DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTI ASTHMA DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTI ASTHMA DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE OF ASTHMA
7.1. OVERVIEW
7.2. TYPE OF ASTHMA MARKET FORECASTS AND ANALYSIS
7.3. ALLERGIC
7.3.1. Overview
7.3.2. Allergic Market Forecast and Analysis
7.4. NON- ALLERGIC
7.4.1. Overview
7.4.2. Non- allergic Market Forecast and Analysis
8. ANTI ASTHMA DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ASTHMA TRIGGER TYPE
8.1. OVERVIEW
8.2. ASTHMA TRIGGER TYPE MARKET FORECASTS AND ANALYSIS
8.3. CHILD-ONSET ASTHMA
8.3.1. Overview
8.3.2. Child-Onset Asthma Market Forecast and Analysis
8.4. ADULT-ONSET ASTHMA
8.4.1. Overview
8.4.2. Adult-Onset Asthma Market Forecast and Analysis
8.5. EXERCISE-INDUCED ASTHMA
8.5.1. Overview
8.5.2. Exercise-Induced Asthma Market Forecast and Analysis
8.6. COUGH-INDUCED ASTHMA
8.6.1. Overview
8.6.2. Cough-Induced Asthma Market Forecast and Analysis
8.7. OCCUPATIONAL ASTHMA
8.7.1. Overview
8.7.2. Occupational Asthma Market Forecast and Analysis
8.8. NOCTURNAL ASTHMA
8.8.1. Overview
8.8.2. Nocturnal Asthma Market Forecast and Analysis
8.9. STEROID-RESISTANT ASTHMA
8.9.1. Overview
8.9.2. Steroid-Resistant Asthma Market Forecast and Analysis
9. ANTI ASTHMA DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
9.1. OVERVIEW
9.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
9.3. BRONCHODILATORS
9.3.1. Overview
9.3.2. Bronchodilators Market Forecast and Analysis
9.4. LEUKOTRIENE ANTAGONISTS
9.4.1. Overview
9.4.2. Leukotriene Antagonists Market Forecast and Analysis
9.5. MAST CELL STABILIZERS
9.5.1. Overview
9.5.2. Mast Cell Stabilizers Market Forecast and Analysis
9.6. CORTICOSTEROIDS
9.6.1. Overview
9.6.2. Corticosteroids Market Forecast and Analysis
9.7. MONOCLONAL ANTIBODY
9.7.1. Overview
9.7.2. Monoclonal Antibody Market Forecast and Analysis
10. ANTI ASTHMA DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
10.1. OVERVIEW
10.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
10.3. ORAL
10.3.1. Overview
10.3.2. Oral Market Forecast and Analysis
10.4. INHALED
10.4.1. Overview
10.4.2. Inhaled Market Forecast and Analysis
10.5. INTRAVENOUS
10.5.1. Overview
10.5.2. Intravenous Market Forecast and Analysis
10.6. SUBCUTANEOUS
10.6.1. Overview
10.6.2. Subcutaneous Market Forecast and Analysis
11. ANTI ASTHMA DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Anti Asthma Drugs Market Overview
11.1.2 North America Anti Asthma Drugs Market Forecasts and Analysis
11.1.3 North America Anti Asthma Drugs Market Forecasts and Analysis - By Type of Asthma
11.1.4 North America Anti Asthma Drugs Market Forecasts and Analysis - By Asthma trigger type
11.1.5 North America Anti Asthma Drugs Market Forecasts and Analysis - By Drug Class
11.1.6 North America Anti Asthma Drugs Market Forecasts and Analysis - By Route of Administration
11.1.7 North America Anti Asthma Drugs Market Forecasts and Analysis - By Countries
11.1.7.1 United States Anti Asthma Drugs Market
11.1.7.1.1 United States Anti Asthma Drugs Market by Type of Asthma
11.1.7.1.2 United States Anti Asthma Drugs Market by Asthma trigger type
11.1.7.1.3 United States Anti Asthma Drugs Market by Drug Class
11.1.7.1.4 United States Anti Asthma Drugs Market by Route of Administration
11.1.7.2 Canada Anti Asthma Drugs Market
11.1.7.2.1 Canada Anti Asthma Drugs Market by Type of Asthma
11.1.7.2.2 Canada Anti Asthma Drugs Market by Asthma trigger type
11.1.7.2.3 Canada Anti Asthma Drugs Market by Drug Class
11.1.7.2.4 Canada Anti Asthma Drugs Market by Route of Administration
11.1.7.3 Mexico Anti Asthma Drugs Market
11.1.7.3.1 Mexico Anti Asthma Drugs Market by Type of Asthma
11.1.7.3.2 Mexico Anti Asthma Drugs Market by Asthma trigger type
11.1.7.3.3 Mexico Anti Asthma Drugs Market by Drug Class
11.1.7.3.4 Mexico Anti Asthma Drugs Market by Route of Administration
11.2. EUROPE
11.2.1 Europe Anti Asthma Drugs Market Overview
11.2.2 Europe Anti Asthma Drugs Market Forecasts and Analysis
11.2.3 Europe Anti Asthma Drugs Market Forecasts and Analysis - By Type of Asthma
11.2.4 Europe Anti Asthma Drugs Market Forecasts and Analysis - By Asthma trigger type
11.2.5 Europe Anti Asthma Drugs Market Forecasts and Analysis - By Drug Class
11.2.6 Europe Anti Asthma Drugs Market Forecasts and Analysis - By Route of Administration
11.2.7 Europe Anti Asthma Drugs Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Anti Asthma Drugs Market
11.2.7.1.1 Germany Anti Asthma Drugs Market by Type of Asthma
11.2.7.1.2 Germany Anti Asthma Drugs Market by Asthma trigger type
11.2.7.1.3 Germany Anti Asthma Drugs Market by Drug Class
11.2.7.1.4 Germany Anti Asthma Drugs Market by Route of Administration
11.2.7.2 France Anti Asthma Drugs Market
11.2.7.2.1 France Anti Asthma Drugs Market by Type of Asthma
11.2.7.2.2 France Anti Asthma Drugs Market by Asthma trigger type
11.2.7.2.3 France Anti Asthma Drugs Market by Drug Class
11.2.7.2.4 France Anti Asthma Drugs Market by Route of Administration
11.2.7.3 Italy Anti Asthma Drugs Market
11.2.7.3.1 Italy Anti Asthma Drugs Market by Type of Asthma
11.2.7.3.2 Italy Anti Asthma Drugs Market by Asthma trigger type
11.2.7.3.3 Italy Anti Asthma Drugs Market by Drug Class
11.2.7.3.4 Italy Anti Asthma Drugs Market by Route of Administration
11.2.7.4 Spain Anti Asthma Drugs Market
11.2.7.4.1 Spain Anti Asthma Drugs Market by Type of Asthma
11.2.7.4.2 Spain Anti Asthma Drugs Market by Asthma trigger type
11.2.7.4.3 Spain Anti Asthma Drugs Market by Drug Class
11.2.7.4.4 Spain Anti Asthma Drugs Market by Route of Administration
11.2.7.5 United Kingdom Anti Asthma Drugs Market
11.2.7.5.1 United Kingdom Anti Asthma Drugs Market by Type of Asthma
11.2.7.5.2 United Kingdom Anti Asthma Drugs Market by Asthma trigger type
11.2.7.5.3 United Kingdom Anti Asthma Drugs Market by Drug Class
11.2.7.5.4 United Kingdom Anti Asthma Drugs Market by Route of Administration
11.2.7.6 Rest of Europe Anti Asthma Drugs Market
11.2.7.6.1 Rest of Europe Anti Asthma Drugs Market by Type of Asthma
11.2.7.6.2 Rest of Europe Anti Asthma Drugs Market by Asthma trigger type
11.2.7.6.3 Rest of Europe Anti Asthma Drugs Market by Drug Class
11.2.7.6.4 Rest of Europe Anti Asthma Drugs Market by Route of Administration
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Anti Asthma Drugs Market Overview
11.3.2 Asia-Pacific Anti Asthma Drugs Market Forecasts and Analysis
11.3.3 Asia-Pacific Anti Asthma Drugs Market Forecasts and Analysis - By Type of Asthma
11.3.4 Asia-Pacific Anti Asthma Drugs Market Forecasts and Analysis - By Asthma trigger type
11.3.5 Asia-Pacific Anti Asthma Drugs Market Forecasts and Analysis - By Drug Class
11.3.6 Asia-Pacific Anti Asthma Drugs Market Forecasts and Analysis - By Route of Administration
11.3.7 Asia-Pacific Anti Asthma Drugs Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Anti Asthma Drugs Market
11.3.7.1.1 Australia Anti Asthma Drugs Market by Type of Asthma
11.3.7.1.2 Australia Anti Asthma Drugs Market by Asthma trigger type
11.3.7.1.3 Australia Anti Asthma Drugs Market by Drug Class
11.3.7.1.4 Australia Anti Asthma Drugs Market by Route of Administration
11.3.7.2 China Anti Asthma Drugs Market
11.3.7.2.1 China Anti Asthma Drugs Market by Type of Asthma
11.3.7.2.2 China Anti Asthma Drugs Market by Asthma trigger type
11.3.7.2.3 China Anti Asthma Drugs Market by Drug Class
11.3.7.2.4 China Anti Asthma Drugs Market by Route of Administration
11.3.7.3 India Anti Asthma Drugs Market
11.3.7.3.1 India Anti Asthma Drugs Market by Type of Asthma
11.3.7.3.2 India Anti Asthma Drugs Market by Asthma trigger type
11.3.7.3.3 India Anti Asthma Drugs Market by Drug Class
11.3.7.3.4 India Anti Asthma Drugs Market by Route of Administration
11.3.7.4 Japan Anti Asthma Drugs Market
11.3.7.4.1 Japan Anti Asthma Drugs Market by Type of Asthma
11.3.7.4.2 Japan Anti Asthma Drugs Market by Asthma trigger type
11.3.7.4.3 Japan Anti Asthma Drugs Market by Drug Class
11.3.7.4.4 Japan Anti Asthma Drugs Market by Route of Administration
11.3.7.5 South Korea Anti Asthma Drugs Market
11.3.7.5.1 South Korea Anti Asthma Drugs Market by Type of Asthma
11.3.7.5.2 South Korea Anti Asthma Drugs Market by Asthma trigger type
11.3.7.5.3 South Korea Anti Asthma Drugs Market by Drug Class
11.3.7.5.4 South Korea Anti Asthma Drugs Market by Route of Administration
11.3.7.6 Rest of Asia-Pacific Anti Asthma Drugs Market
11.3.7.6.1 Rest of Asia-Pacific Anti Asthma Drugs Market by Type of Asthma
11.3.7.6.2 Rest of Asia-Pacific Anti Asthma Drugs Market by Asthma trigger type
11.3.7.6.3 Rest of Asia-Pacific Anti Asthma Drugs Market by Drug Class
11.3.7.6.4 Rest of Asia-Pacific Anti Asthma Drugs Market by Route of Administration
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Anti Asthma Drugs Market Overview
11.4.2 Middle East and Africa Anti Asthma Drugs Market Forecasts and Analysis
11.4.3 Middle East and Africa Anti Asthma Drugs Market Forecasts and Analysis - By Type of Asthma
11.4.4 Middle East and Africa Anti Asthma Drugs Market Forecasts and Analysis - By Asthma trigger type
11.4.5 Middle East and Africa Anti Asthma Drugs Market Forecasts and Analysis - By Drug Class
11.4.6 Middle East and Africa Anti Asthma Drugs Market Forecasts and Analysis - By Route of Administration
11.4.7 Middle East and Africa Anti Asthma Drugs Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Anti Asthma Drugs Market
11.4.7.1.1 South Africa Anti Asthma Drugs Market by Type of Asthma
11.4.7.1.2 South Africa Anti Asthma Drugs Market by Asthma trigger type
11.4.7.1.3 South Africa Anti Asthma Drugs Market by Drug Class
11.4.7.1.4 South Africa Anti Asthma Drugs Market by Route of Administration
11.4.7.2 Saudi Arabia Anti Asthma Drugs Market
11.4.7.2.1 Saudi Arabia Anti Asthma Drugs Market by Type of Asthma
11.4.7.2.2 Saudi Arabia Anti Asthma Drugs Market by Asthma trigger type
11.4.7.2.3 Saudi Arabia Anti Asthma Drugs Market by Drug Class
11.4.7.2.4 Saudi Arabia Anti Asthma Drugs Market by Route of Administration
11.4.7.3 U.A.E Anti Asthma Drugs Market
11.4.7.3.1 U.A.E Anti Asthma Drugs Market by Type of Asthma
11.4.7.3.2 U.A.E Anti Asthma Drugs Market by Asthma trigger type
11.4.7.3.3 U.A.E Anti Asthma Drugs Market by Drug Class
11.4.7.3.4 U.A.E Anti Asthma Drugs Market by Route of Administration
11.4.7.4 Rest of Middle East and Africa Anti Asthma Drugs Market
11.4.7.4.1 Rest of Middle East and Africa Anti Asthma Drugs Market by Type of Asthma
11.4.7.4.2 Rest of Middle East and Africa Anti Asthma Drugs Market by Asthma trigger type
11.4.7.4.3 Rest of Middle East and Africa Anti Asthma Drugs Market by Drug Class
11.4.7.4.4 Rest of Middle East and Africa Anti Asthma Drugs Market by Route of Administration
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Anti Asthma Drugs Market Overview
11.5.2 South and Central America Anti Asthma Drugs Market Forecasts and Analysis
11.5.3 South and Central America Anti Asthma Drugs Market Forecasts and Analysis - By Type of Asthma
11.5.4 South and Central America Anti Asthma Drugs Market Forecasts and Analysis - By Asthma trigger type
11.5.5 South and Central America Anti Asthma Drugs Market Forecasts and Analysis - By Drug Class
11.5.6 South and Central America Anti Asthma Drugs Market Forecasts and Analysis - By Route of Administration
11.5.7 South and Central America Anti Asthma Drugs Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Anti Asthma Drugs Market
11.5.7.1.1 Brazil Anti Asthma Drugs Market by Type of Asthma
11.5.7.1.2 Brazil Anti Asthma Drugs Market by Asthma trigger type
11.5.7.1.3 Brazil Anti Asthma Drugs Market by Drug Class
11.5.7.1.4 Brazil Anti Asthma Drugs Market by Route of Administration
11.5.7.2 Argentina Anti Asthma Drugs Market
11.5.7.2.1 Argentina Anti Asthma Drugs Market by Type of Asthma
11.5.7.2.2 Argentina Anti Asthma Drugs Market by Asthma trigger type
11.5.7.2.3 Argentina Anti Asthma Drugs Market by Drug Class
11.5.7.2.4 Argentina Anti Asthma Drugs Market by Route of Administration
11.5.7.3 Rest of South and Central America Anti Asthma Drugs Market
11.5.7.3.1 Rest of South and Central America Anti Asthma Drugs Market by Type of Asthma
11.5.7.3.2 Rest of South and Central America Anti Asthma Drugs Market by Asthma trigger type
11.5.7.3.3 Rest of South and Central America Anti Asthma Drugs Market by Drug Class
11.5.7.3.4 Rest of South and Central America Anti Asthma Drugs Market by Route of Administration
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ANTI ASTHMA DRUGS MARKET, KEY COMPANY PROFILES
13.1. GLAXOSMITHKLINE PLC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. MERCK AND CO., INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ASTRAZENECA PLC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. F. HOFFMANN-LA ROCHE LTD
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. TEVA PHARMACEUTICAL INDUSTRIES
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NOVARTIS INTERNATIONAL AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BOEHRINGER INGELHEIM
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SUNOVION PHARMACEUTICALS INC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PFIZER, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ABBOTT LABORATORIES
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. GlaxoSmithKline plc.
2. Merck and Co., Inc.
3. AstraZeneca plc.
4. F. Hoffmann-La Roche Ltd
5. Teva Pharmaceutical Industries
6. Novartis International AG
7. Boehringer Ingelheim
8. Sunovion Pharmaceuticals Inc
9. Pfizer, Inc.
10. Abbott Laboratories
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For